← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Als Therapy Development Fnd
$4,590,640
Total funding
5
Grants
Funding over time
peak $2.5M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
DOD$4,590,640 · 5
By mechanism
—$4,590,640 · 5
Investigators at Als Therapy Development Fnd
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
DEVELOPMENT OF THERAPEUTIC INTERVENTIONS FOR AMYOTROPHIC LATERAL SCLEROSOS$2,527,000
· FY2009 · Department of the Army
ANTI-CD40 LIGAND THERAPY FOR SLOWING PROGRESSION AND EXTENDING LIFE IN AMYOTROPHIC LATERAL SCLEROSIS$645,900
· FY2017 · Department of the Army
PHARMACOLOGICAL INHIBITION OF TRAF2- AND NCK-INTERACTING KINASE (TNIK) AS A TREATMENT FOR ALS$586,740
· FY2025 · Defense Health Agency
TYPE I PRMT INHIBITOR PRECLINICAL PHARMACOLOGY FOR ALS$550,000
· FY2022 · Defense Health Agency
PROTEOMICS BLOOD-BASED BIOMARKER DISCOVERY FOR ALS$281,000
· FY2021 · Defense Health Agency